Mercator Medical (FRA:MM2) 3-Year Sortino Ratio: 0.93 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MM2 Mercator Medical SA FRA:MM2
58 GF Score
Price €12.62
GF Value €11.46
! 6 Warning Signs
View Full Analysis

What is Mercator Medical 3-Year Sortino Ratio?

Mercator Medical FRA:MM2 -0.63% 58 3-Year Sortino Ratio is 0.93 as of Sep. 09, 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 58/100 and a GF Value™ of €11.46. The stock has 6 warning signs investors should review.

The 3-Year Sortino Ratio measures the additional return that an investor receives per unit of the downside risk over the past three years. As of today (2026-09-09), Mercator Medical's 3-Year Sortino Ratio is 0.93.


Mercator Medical  (FRA:MM2) 3-Year Sortino Ratio Explanation

The 3-Year Sortino Ratio inidicates the risk-adjusted return of an investment over the past three year. It is calculated as the annualized result of the average three-year monthly excess returns divided by the standard deviation of negative returns in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

Differnt from the Sharpe Ratio that penalizes both upside and downside volatility equally, the Sortino Ratio penalizes only those returns falling below a user-specified target or required rate of return. The expected returns here is set to the risk-free rate as well.


Mercator Medical 3-Year Sortino Ratio Related Terms


FRA:MM2 vs ISRG, BDX, RMD: 3-Year Sortino Ratio Comparison

For the Medical Instruments & Supplies subindustry, Mercator Medical's 3-Year Sortino Ratio, along with its competitors' market caps and 3-Year Sortino Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercator Medical 3-Year Sortino Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's 3-Year Sortino Ratio distribution charts can be found below:

* The bar in red indicates where Mercator Medical's 3-Year Sortino Ratio falls into.


FRA:MM2
58GF Score
Mercator Medical SA FRA:MM2
3-Year Sortino Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical 3-Year Sortino Ratio Calculation

The 3-Year Sortino Ratio measures the risk-adjusted return of an investment asset or portfolio in the last three year, focusing specifically on downside risk rather than total risk. A stock / portfolio's 3-Year Sortino Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the downside risks over the past three year.

A downside risk is a potential loss from the asset or investment. The Downside risk here is measured by the downside deviation, which is the standard deviation of negative returns.

Frequently Asked Questions Learn more about 3-Year Sortino Ratio →
What does a 3-Year Sortino Ratio of 0.93 mean?
Mercator Medical (FRA:MM2) has a 3-Year Sortino Ratio of 0.93 as of Sep. 09, 2026. 3-Year Sortino Ratio measures the additional return that an investor receives per unit of the downside risk over the past three years. View historical data for Mercator Medical and its competitors.
Is Mercator Medical's 3-Year Sortino Ratio too high?
Mercator Medical's current 3-Year Sortino Ratio is 0.93. Overall, Mercator Medical has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's 3-Year Sortino Ratio compare to ISRG and BDX?
Mercator Medical's 3-Year Sortino Ratio of 0.93 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Sortino Ratio for a Medical Devices & Instruments company?
A good 3-Year Sortino Ratio depends on the Medical Devices & Instruments industry context. However, 3-Year Sortino Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Sortino Ratio mean?
A high 3-Year Sortino Ratio can signal that a stock is expensive relative to its fundamentals. 3-Year Sortino Ratio measures the additional return that an investor receives per unit of the downside risk over the past three years. View historical data for Mercator Medical and its competitors. Mercator Medical's current 3-Year Sortino Ratio is 0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Mercator Medical (FRA:MM2) has a current 3-Year Sortino Ratio of 0.93. The stock's GF Value™ is €11.46, compared to a current price of €12.62 — trading 10.1% above its estimated fair value. The current 3-Year Sortino Ratio is 0.93. Mercator Medical's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Sortino Ratio calculated?
3-Year Sortino Ratio is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current 3-Year Sortino Ratio is 0.93 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of €12.62 is trading 10.1% above its estimated GF Value™ of €11.46.

Key valuation signals for FRA:MM2:

  • 3-Year Sortino Ratio: 0.93
  • GF Value™: €11.46 vs. price of €12.62 (10.1% above fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
58GF Score

Get the complete analysis for FRA:MM2

3-Year Sortino Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.62
Price
€11.46
GF Value